Chrysos Corporation CEO Dirk Treasure says the company expects to accelerate deployment of its PhotonAssay mineral sample X-ray units in fiscal 2027 after sample volumes hit a record 11.3 million in FY26 and a new monthly high was recorded in July.
“More mines and labs are choosing PhotonAssay for safer, faster, more accurate analysis,” Treasure said.
“Uptake of our PhotonAssay technology is demonstrated by a 67% increase in samples processed during FY26 and our future rollout is now supported by an additional 24 contracts signed during the period.”
ASX-listed Chrysos is guiding for FY27 EBITDA of A$35-42 million on revenue of $108-118 million after reporting 68% and 33% year-on-year increases, respectively, to $27.2 million EBITDA and $88.1 million revenue in FY26.
PhotonAssay samples processed topped one million for five consecutive months to end FY26 and then a record 1.1 million-plus processed in July.
Chrysos has 87 contracted PhotonAssay units including the first generation “XN” machine deployed in Western Australia. It said it was operating cashflow positive in FY26 with $17.9 million in net inflows.
Cash in hand of $25.9 million plus $140 million in undrawn debt put the company in a position to increase PhotonAssay manufacturing, it said.
Chrysos is replacing traditional fire assaying with its non-destructive, non-chemical analytical method.
